Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“Hats off to HLTH Inc. for focusing the entire opening session on the criticality of clinical trials. Too few patients are even asked about clinical trials – the most advanced form of cancer care – and less than 7% participate.
As this compelling panel (consistent of a remarkable patient, an actor with a passion, and an oncology leader) underscored, cancer research saves lives!”
More posts featuring Karen Knudsen.